At the hospital level, this may have the added benefit of decreasing LOS and hastening recovery.

Conclusions: Decreased LOS mandated by the need for a cost-efficiency path does not adversely affect patient satisfaction.

Conclusion: Inflammatory bowel disease patients benefit from the use of ERP, demonstrating decreased LOS and costs without an increase in complications and readmissions.